BC is classified into four molecular subtypes (luminal A, luminal B, HER2+, and triple-negative/basal-like), for which the presence of some receptors in the tumor cell membrane in the analyzed biopsy through the immunohistochemistry is considered as a grouping criterion [7]. The gene discussed is ERBB2; the disease is neoplasm.